Immune Design Corp. Company Profile (NASDAQ:IMDZ)

About Immune Design Corp.

Immune Design Corp. is a clinical stage immunotherapy company. The Company focuses on cancer with in vivo approaches designed to enable the body's immune system to fight disease. The Company is developing multiple product candidates from its discovery platforms, including ZVex and GLAAS. ZVex is a discovery platform that uses a vector to generate product candidates designed to create cytotoxic T cells (CTLs) in vivo. The ZVex vector is a delivery system based on a hybrid, re-engineered virus designed to carry the genetic information of selected tumor antigen in whole or selected epitopes selectively to dendritic cells (DCs) in the skin. When injected into a cancer patient, a ZVex-based product candidate is designed to interact only with these DCs, delivering the tumor antigen in the form of ribonucleic acid (RNA). GLA Adjuvant Systems (GLAAS) is a discovery platform that works in vivo and is based on a synthetic molecule called glucopyranosyl lipid A (GLA).

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Exchange: NASDAQ
• Symbol: IMDZ
• CUSIP:

Key Metrics:

• Previous Close: $7.58
• 50 Day Moving Average: $7.11
• 200 Day Moving Average: $10.08
• 52-Week Range: $6.02 - $23.55
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -2.68
• P/E Growth: -0.60
• Market Cap: $152.93M
• Outstanding Shares: 20,175,000
• Beta: 2.67

Profitability:

• Net Margins: -525.30%
• Return on Equity: -44.57%
• Return on Assets: -41.51%

Debt:

• Current Ratio: 9.13%
• Quick Ratio: 9.06%

Additional Links:

• Visit Immune Design Corp.'s Official Website
• View IMDZ on Google Finance
• View IMDZ on Yahoo Finance
• View IMDZ's Company Profile on Reuters
• Search for Immune Design Corp. on Google

Companies Related to Immune Design Corp.:

• Senseonics Holdings (NYSEMKT:SENS)
• LeMaitre Vascular (NASDAQ:LMAT)
• Proteostasis Therapeutics (NASDAQ:PTI)
• Adamas Pharmaceuticals (NASDAQ:ADMS)
• Versartis (NASDAQ:VSAR)
• Clearside Biomedical (NASDAQ:CLSD)
• Cytokinetics (NASDAQ:CYTK)
• Computer Programs and Systems (NASDAQ:CPSI)
• Geron Corp. (NASDAQ:GERN)
• Organovo Holdings (NASDAQ:ONVO)

Earnings

Earnings History for Immune Design Corp. (NASDAQ:IMDZ)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/10/2016
8/9/2016	Q2	($0.68)	($0.71)			View	N/A
5/10/2016	Q1	($0.62)	($0.61)			View	Listen
3/10/2016	Q4	($0.54)	($0.60)	$1.06 million	$1.10 million	View	Listen
11/12/2015	Q315	($0.39)	($0.37)	$4.10 million	$4.70 million	View	Listen
8/12/2015	Q215	($0.47)	($0.54)	$1.71 million		View	Listen
5/14/2015	Q115	($0.64)	($0.56)	$1.30 million	$1.90 million	View	Listen
3/31/2015		($0.68)	($0.78)			View	Listen
11/12/2014	Q3 14	($0.36)	($0.55)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Immune Design Corp. (NASDAQ:IMDZ)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.56)	($0.56)	($0.56)
Q2 2016	2	($0.75)	($0.63)	($0.69)
Q3 2016	2	($0.72)	($0.66)	($0.69)
Q4 2016	2	($0.68)	($0.61)	($0.65)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Immune Design Corp. (NASDAQ:IMDZ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Immune Design Corp. (NASDAQ:IMDZ)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/20/2016	Group L P Column	Major Shareholder	Buy	800,000	$6.25	$5,000,000.00
9/20/2016	Lewis W Coleman	Director	Buy	40,000	$6.25	$250,000.00
7/15/2016	Stephen R Brady	EVP	Buy	1,500	$6.84	$10,260.00
11/23/2015	Wayne Gombotz	insider	Sell	5,000	$20.00	$100,000.00
9/14/2015	Wayne Gombotz	insider	Sell	5,000	$16.19	$80,950.00
8/25/2015	Lewis W Coleman	Director	Buy	3,000	$14.50	$43,500.00
5/12/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	177,607	$21.60	$3,836,311.20
4/24/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	82,892	$26.81	$2,222,334.52
4/21/2015	Franklin M Berger	Director	Buy	25,000	$26.50	$662,500.00
4/21/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	45,820	$26.51	$1,214,688.20
4/16/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	53,914	$28.23	$1,521,992.22
4/7/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	7,495	$26.72	$200,266.40
3/25/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	18,156	$27.64	$501,831.84
3/23/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	44,464	$27.52	$1,223,649.28
3/18/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	50,309	$26.09	$1,312,561.81
3/12/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	129,342	$24.94	$3,225,789.48
3/9/2015	Proquest Investments Iv, L.P.	Major Shareholder	Sell	39,446	$25.45	$1,003,900.70
7/29/2014	Alta Partners Viii, L.P.	Major Shareholder	Buy	299,559	$12.00	$3,594,708.00
7/29/2014	Franklin M Berger	Director	Buy	50,000	$12.00	$600,000.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Immune Design Corp. (NASDAQ:IMDZ)

Date	Headline
	Immune Design's (IMDZ) GLAAS Discovery Platform Utilized in Sanofi Phase 1 for Peanut Allergy Therapy (NASDAQ:IMDZ) www.streetinsider.com - September 29 at 5:34 PM
	Immune Design Announces Advancement of First GLAAS™-based Allergy Program into Clinical Development (NASDAQ:IMDZ) www.publicnow.com - September 28 at 10:28 AM
	Thursday 9/22 Insider Buying Report: IMDZ, AMBC (NASDAQ:IMDZ) www.4-traders.com - September 22 at 3:39 PM
	Immune Design Prices Public Offering of Common Stock (NASDAQ:IMDZ) www.nasdaq.com - September 16 at 5:29 PM
	IMMUNE DESIGN CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement (NASDAQ:IMDZ) biz.yahoo.com - September 16 at 5:29 PM
	Immune Design : Prices Public Offering of Common Stock (NASDAQ:IMDZ) www.4-traders.com - September 16 at 9:31 AM
	Immune Design (IMDZ) Plans Public Offering of Common Stock (NASDAQ:IMDZ) www.streetinsider.com - September 15 at 8:46 AM
	Immune Design Announces Proposed Public Offering of Common Stock (NASDAQ:IMDZ) www.publicnow.com - September 14 at 5:42 PM
	IMMUNE DESIGN CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:IMDZ) biz.yahoo.com - September 14 at 5:42 PM
	Biotech stocks reeling after Hillary Clinton criticizes drug prices (NASDAQ:IMDZ) www.bizjournals.com - August 25 at 10:38 AM
	New Study: Immune Design Corp. (IMDZ) - Financial and Strategic SWOT Analysis Review (NASDAQ:IMDZ) www.live-pr.com - August 24 at 8:42 AM
	ETF’s with exposure to Immune Design Corp. : August 22, 2016 (NASDAQ:IMDZ) www.capitalcube.com - August 22 at 5:40 PM
	Immune Design Corp. :IMDZ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:IMDZ) www.capitalcube.com - August 12 at 5:42 PM
	Immune Design's (IMDZ) CEO Carlos Paya on Q4 2016 Results - Earnings Call Transcript (NASDAQ:IMDZ) seekingalpha.com - August 11 at 8:39 AM
	Immune Design reports 2Q loss (NASDAQ:IMDZ) sg.finance.yahoo.com - August 10 at 8:29 AM
	Immune Design Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:IMDZ) www.publicnow.com - August 9 at 5:46 PM
	Q2 2016 Immune Design Corp Earnings Release - After Market Close (NASDAQ:IMDZ) biz.yahoo.com - August 9 at 8:36 AM
	Immune Design (IMDZ): Stock to Disappoint on Q2 Earnings? (NASDAQ:IMDZ) finance.yahoo.com - August 5 at 8:35 AM
	Immune Design Corp.: Immune Design to Report Second Quarter 2016 Financial Results (NASDAQ:IMDZ) www.twst.com - August 2 at 5:51 PM
	Immune Design to Report Second Quarter 2016 Financial Results (NASDAQ:IMDZ) www.publicnow.com - August 2 at 10:26 AM
	ETF’s with exposure to Immune Design Corp. : July 21, 2016 (NASDAQ:IMDZ) www.capitalcube.com - July 21 at 2:08 PM
	New Market Lows Stock Leaders – AVGR, CLDC, IMDZ, RGNX, IMGN, CVI, XPLR (NASDAQ:IMDZ) www.fxpips.com - July 14 at 9:07 AM
	IMMUNE DESIGN CORP. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:IMDZ) biz.yahoo.com - July 1 at 5:13 PM
	Immune Design Appoints Susan L. Kelley, M.D. to Board of Directors (NASDAQ:IMDZ) www.publicnow.com - June 16 at 8:39 AM
	Analysts Forecast 33% Upside For IBB (NASDAQ:IMDZ) www.nasdaq.com - June 8 at 5:54 PM
	Immune Design Releases New PFS, OS and TME Data from Trials of Three Immuno-Oncology Product Candidates (NASDAQ:IMDZ) www.publicnow.com - June 8 at 8:08 AM
	Immune Design Announces Upcoming Events (NASDAQ:IMDZ) finance.yahoo.com - June 1 at 8:00 AM
	Immune Design (IMDZ) Q1 Earnings: What Awaits the Stock? (NASDAQ:IMDZ) finance.yahoo.com - May 6 at 7:16 PM
	IMMUNE DESIGN CORP. Files SEC form 10-K, Annual Report (NASDAQ:IMDZ) biz.yahoo.com - March 15 at 6:09 AM
	Immune Design Loss Wider than Expected, Pipeline in Focus (NASDAQ:IMDZ) finance.yahoo.com - March 11 at 9:30 AM
	Immune Design reports 4Q loss (NASDAQ:IMDZ) sg.finance.yahoo.com - March 10 at 4:29 PM
	IMMUNE DESIGN CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (NASDAQ:IMDZ) biz.yahoo.com - March 10 at 4:23 PM
	Immune Design Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update (NASDAQ:IMDZ) finance.yahoo.com - March 10 at 4:01 PM
	Q4 2015 Immune Design Corp Earnings Release - After Market Close (NASDAQ:IMDZ) biz.yahoo.com - March 10 at 7:07 AM
	What Awaits Immune Design (IMDZ) this Earnings Season? (NASDAQ:IMDZ) finance.yahoo.com - March 8 at 10:10 AM
	Immune Design’s GLAAS™ Platform Shown to Modulate the Allergic Immune Response (NASDAQ:IMDZ) finance.yahoo.com - March 4 at 8:00 AM
	Immune Design to Report Fourth Quarter and Year End 2015 Financial Results (NASDAQ:IMDZ) finance.yahoo.com - March 3 at 8:00 AM
	Immune Design to Present at Cowen and Company 36th Annual Health Care Conference (NASDAQ:IMDZ) finance.yahoo.com - February 29 at 8:00 AM
	Immune Design Corp (IMDZ) is Trading Higher on Unusual Volume for February 24 - Equities.com (NASDAQ:IMDZ) www.equities.com - February 26 at 10:24 AM
	Does Immune Design Corp Have Any Gas After Today's Huge Decline? - Franklin Independent (NASDAQ:IMDZ) www.franklinindependent.com - February 20 at 2:55 PM
	IMMUNE DESIGN CORP. Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:IMDZ) biz.yahoo.com - February 16 at 4:40 PM
	Immune Design (IMDZ) Issues Positive Update from Ongoing CMB305 and G100 Phase 1s (NASDAQ:IMDZ) www.streetinsider.com - February 9 at 1:31 PM
	8:03 am Immune Design reports 'Positive' Topline Data From Three Phase 1 Clinical Trials of Immuno-oncology Product Candidates (NASDAQ:IMDZ) finance.yahoo.com - February 9 at 8:03 AM
	Immune Design Announces Positive Topline Data From Three Phase 1 Clinical Trials of Immuno-oncology Product Candidates (NASDAQ:IMDZ) finance.yahoo.com - February 9 at 8:00 AM
	Immune Design to Present at Leerink Partners 5th Annual Global Healthcare Conference (NASDAQ:IMDZ) finance.yahoo.com - February 4 at 8:00 AM
	Immune Design is Now Oversold (IMDZ) (NASDAQ:IMDZ) www.thestreet.com - February 3 at 12:42 PM
	Genocea Doses Patients in Phase IIb Study on GEN-003 (NASDAQ:IMDZ) finance.yahoo.com - February 1 at 7:02 PM
	ImmunoGen Posts Wider-than-Expected Loss, Retains View (NASDAQ:IMDZ) finance.yahoo.com - February 1 at 10:10 AM
	Immune Design Corp. (IMDZ) (NASDAQ:IMDZ) finance.yahoo.com - January 29 at 12:40 PM
	Immune Design Posts Narrower-Than-Expected Loss for Q3 (NASDAQ:IMDZ) finance.yahoo.com - November 13 at 10:35 AM

Social

Immune Design Corp. (NASDAQ:IMDZ) Chart for Saturday, October, 1, 2016